Dimercaptopropanesulfonate Sodium — Class II drug recall D-0821-2020
Terminated recall by McGuff Compounding Pharmacy Services, Inc., reported 2020-02-05, distributed in AK, AZ, CA, CO, DC, FL, IN, MA…. Presence of Particulate Matter: Particulates observed in vials release for dispensing.
| Recall number | D-0821-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | McGuff Compounding Pharmacy Services, Inc., Santa Ana, CA, United States |
| Recall initiated | 2019-02-14 |
| Classified | 2020-01-29 |
| Reported by FDA | 2020-02-05 |
| Terminated | 2023-11-20 |
| Distributed | AK, AZ, CA, CO, DC, FL, IN, MA, MT, NC, NJ, NY, OR, SC, TX, UT, VA, WA, WI |
| Reason classes | specification failure |
| Lot numbers | 18J1081 |
| Expiration dates | 2019-03-10 |
Product
Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL 5 mL SDV, Rx only, McGuff Compounding Pharmacy Services, Inc. Santa Ana, CA 92704
Reason for recall
Presence of Particulate Matter: Particulates observed in vials release for dispensing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0821-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.